Cargando…
Biosimilars in inflammatory bowel disease: A review of post-marketing experience
Biologic compounds are obtained from living organisms or cell cultures by means of biotechnology methods. A similar biologic drug, commonly called biosimilar, is a product copied by a native approved biologic drug whose license has expired. Biosimilar drugs usually are marketed at a lower price and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5236499/ https://www.ncbi.nlm.nih.gov/pubmed/28127193 http://dx.doi.org/10.3748/wjg.v23.i2.197 |